Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INTERACT: Intravenous Iron and ESA in Renal Transplant Recipients
KCT0008143Phase 4Recruiting
- Sponsor
- Ministry of Health & Welfare
- Start
- Mar 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Iron in end-stage kidney disease (ESKD), anaemia, sponsored by Ministry of Health & Welfare. Started Mar 2023; status: recruiting.
02
Drugs
Iron
03
Conditions
end-stage kidney disease (ESKD)anaemia
Beyond the preview
Go deeper on KCT0008143.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0008143.